Research of Budesonide and Compound Ipratropium Bromide Aerosol Inhalation on Acute Exacerbation of COPD

Objective: To explore in pre-hospital emergency COPD acute onset of budesonide combined with compound ipratropium bromide aerosol treatment effect. Methods: 110 cases of pre-hospital emergency COPD patients with acute onset were divided randomly divided into two groups. On the basis of the conventional treatment, the observation group was treated with budesonide and compound ipratropium bromide aerosol inhalation. The control group only was treated with compound ipratropium bromide aerosol inhalation. Treatment in the two groups were observed before treatment and after 30 minutes to symptom relief, oxygen saturation, adverse reaction. Results: The two groups after treatment could get in 30 minutes the remission of symptoms, but the observation group relief time was earlier than that of control group(P0.05), 30 minutes after treatment with oxygen saturation had significant difference(P0.05), and the observation group discomfort reaction was less. Conclusion: Budesonide and compound ipratropium bromide aerosol inhalation in treatment of acute exacerbation of COPD has fast effect, convenient application, simple operation, and fewer adverse reactions, which is safe and reliable.